News

09 May 2019

Raúl Zamora

  • Medicina Translacional

Raúl Zamora wins the 2nd edition of the Jesús Serra Foundation Research Awards

The researcher Raúl Zamora Ros, from the Bellvitge Biomedical Research Institute (IDIBELL) and the Catalan Institute of Oncology (ICO), has been chosen by the jury of the Jesús Serra Foundation Research Awards as the winner in the clinical research category.

09 May 2019

Integrants de l'IDIBELL dels darrers 15 anys al pati de la Universitat de Barcelona

IDIBELL celebrates 15 years

Yesterday, Wednesday 8th May 2019, the commemoration of the 15th anniversary of the Bellvitge Biomedical Research Institute (IDIBELL) took place in the Paranymph of the historic building of the University of Barcelona.

02 May 2019

La Dra. Antonella Consiglio (al centre) juntament amb els membres del seu laboratori que han participat en l'estudi.

  • Medicina Regenerativa
  • Neurociències

Fluorescent dopaminergic neurons to accelerate Parkinson’s disease research

A team of scientists led by Dr. Antonella Consiglio from the IDIBELL and the University of Barcelona (UB), and Dr.

25 April 2019

•    Molt Hble. Sr. Joaquim Torra i Pla, President de la Generalitat de Catalunya 
•    H. Sra. Alba Vergés i Bosch, Consellera de Salut de la Generalitat de Catalunya
•    Dr. Gabriel Capellá, director IDIBELL
•    Prof. Dr. Angel Raya, director CMR[B] i del P-CMR[C]
•    Excma. Sra. Núria Marín, alcaldessa de l’Hospitalet

  • Medicina Regenerativa

The new Program for Regenerative Medicine in Catalonia has officially launched

The new Clinical Translational Program for Regenerative Medicine in Catalonia (P-CMR [C]), propelled by the Center of Regenerative Medicine in Barcelona (CMR[B]) and the Bellvitge Biomedical Research Institute (IDIBELL), were officially presented this morning in their new facilities, set in the D

16 April 2019

El Dr. David G. Molleví i la Dra. Natalia Guillén Díaz-Maroto, de l'IDIBELL-ICO

  • Càncer

IDIBELL – ICO researchers set new bases to develop therapies against colorectal cancer